| | Translational Research in the GOG and the Committee on Experimental Medicine M Birrer, WT Beck The Gynecologic Oncology Group: 43 Years of Success, 64, 2013 | | 2013 |
| 0024: Clusterin Confers Proliferation and Paclitaxel Resistance in Ovarian Cancer DC Park, SG Yeo, MR Wilson, MJ Birrer, EY Shin, WR Welch, CA Bandera, ... International Journal of Gynecological Cancer 16 (Suppl 3), 605-606, 2006 | | 2006 |
| 0330: Identification and Characterization of Important Signalling Pathways in Serous Ovarian Tumors MJ Birrer, ME Johnson, T Bonome, H Donninger, K Wong, DC Park, ... International Journal of Gynecologic Cancer 16 (Suppl 3), 2006 | | 2006 |
| 1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN … J Ledermann, N Colombo, A Oza, K Fujiwara, MJ Birrer, L Randall, ... International journal of gynecological cancer 30 (Suppl 3), A1-A1, 2020 | 2 | 2020 |
| 1061 POSTER Foxo3a Loss is a Key Event in High-grade Pelvic Serous Carcinogenesis K Levanon, M Hirsch, A Miron, A Ligon, M Birrer, R Drapkin European Journal of Cancer 47, S113-S114, 2011 | | 2011 |
| 161 Leveraging a novel DNA barcoding platform for integrated profiling and pharmacodynamic readouts C Castro, V Peterson, A Ullal, S Agasti, S Tuang, N Miller, M Birrer, ... European Journal of Cancer, 54, 2014 | | 2014 |
| 18/# 499 Mirvetuximab soravtansine and carboplatin for treatment of patients with recurrent folate receptor alpha-positive platinum-sensitive ovarian cancer: a final analysis K Moore, D O’Malley, I Vergote, L Martin, A Gonzalez-Martin, J Wang, ... International Journal of Gynecologic Cancer 32 (Suppl 3), 2022 | 3 | 2022 |
| 2005 Ovarian Cancer State of the Science Meeting Participants MJ Birrer, J Fountain, EL Trimble | | |
| 2022-RA-1519-ESGO Biomarker testing and first line maintenance treatment patterns in a real-world US cohort of patients with advanced ovarian cancer DS Veljovich, RT Penson, MJ Birrer, G Long, G Wetherill, S Volpe International Journal of Gynecologic Cancer 32 (Suppl 2), 2022 | | 2022 |
| 2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent … A Oaknin, D Lorusso, A Oza, N Colombo, T van Gorp, D O’Malley, ... International Journal of Gynecologic Cancer 32 (Suppl 2), 2022 | 2 | 2022 |
| 3D perfusion bioreactor system as a model for studying cell biology of ovarian cancer. A Martinez, M Buckley, J Berry, R Arend, M Birrer CLINICAL CANCER RESEARCH 26 (13), 86-86, 2020 | | 2020 |
| 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian … KN Moore, AM Oza, N Colombo, A Oaknin, G Scambia, D Lorusso, ... Annals of Oncology 33, S790-S791, 2022 | 2 | 2022 |
| 592P Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer UA Matulonis, KN Moore, D Lorusso, A Oaknin, S Pignata, H Denys, ... Annals of Oncology 33, S817, 2022 | 1 | 2022 |
| 605P Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer KN Moore, D Lorusso, A Oaknin, S Pignata, H Denys, N Colombo, ... Annals of Oncology 33, S822-S823, 2022 | 3 | 2022 |
| 76 Patients (PTS) with recurrent gynecologic cancer whose tumors have activating wnt pathway mutations respond better to DKN-01, a DICKKOPF-1 (DKK1) inhibitor R Arend, C Castro, U Matulonis, E Hamilton, C Gunderson, K LyBarger, ... International Journal of Gynecologic Cancer 29 (Suppl 3), 2019 | 3 | 2019 |
| 843P Association of gene expression signatures and TMB with response to pembrolizumab (pembro) in patients (pts) with recurrent ovarian cancer (ROC) enrolled in KEYNOTE-100 JA Ledermann, R Shapira-Frommer, AD Santin, A Lisyanskaya, S Pignata, ... Annals of Oncology 31, S631-S632, 2020 | 4 | 2020 |
| 879TiP Phase II study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in platinum-experienced advanced cervical cancer MJ Birrer, LR Mileshkin, K Fujiwara, I Ray-Coquard, J Alexandre, ... Annals of Oncology 31, S644-S645, 2020 | 5 | 2020 |
| A 7-TRANSCRIPT CLASSIFIER IDENTIFIES METASTATIC DISEASE AND WORSE PROGRESSION-FREE SURVIVAL IN ENDOMETRIOID ENDOMETRIAL CANCER PATIENTS Y Casablanca, G Wang, C Tian, NW Bateman, J Miecznikowski, C Miller, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 26, 154-155, 2016 | | 2016 |
| A complex pattern of translational initiation and phosphorylation in L-myc proteins. H Dosaka-Akita, RK Rosenberg, JD Minna, MJ Birrer Oncogene 6 (3), 371-378, 1991 | 35 | 1991 |
| A comprehensive pan-cancer molecular study of gynecologic and breast cancers AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ... Cancer cell 33 (4), 690-705. e9, 2018 | 556 | 2018 |
